Search results
Jump to navigation
Jump to search
- info - Home https://psychonautwiki.org/wiki/File:Behandeling-4-fa-intoxicatie.pdf https://psychonautwiki.org/wiki/File:4-FA%20risicobeoordeling%20(2016)21 KB (3,439 words) - 15:42, 30 July 2022
- In order to maintain consistency across the wiki, images of molecular structures should be produced in a standardized format rather than obtained from19 KB (857 words) - 09:55, 15 September 2022
- action involves promoting release of the neurotransmitters dopamine and norepinephrine. It was first synthesized in 1887, but its psychostimulant effects were41 KB (5,607 words) - 19:01, 7 April 2024
- acuminata - DMT-Nexus Wiki Acacia baileyana Wikipedia | https://en.wikipedia.org/wiki/Acacia_baileyana Acacia baileyana - DMT-Nexus Wiki Acacia burkittii70 KB (623 words) - 05:02, 26 April 2024
- releases a dopamine:norepinephrine ratio of ~1:1.3 from synapses versus ~1:2 for d-amphetamine. Their effect on the norepinephrine (NET) and dopamine (DAT)41 KB (5,798 words) - 13:29, 16 April 2024
- but it likely produces its effects by increasing levels of dopamine, norepinephrine, and serotonin in the brain. 4-FMA was first detected being sold in21 KB (3,467 words) - 16:14, 30 July 2022
- thought to act primarily as a potent norepinephrine-dopamine reuptake inhibitor. Reduced re-uptake of norepinephrine and dopamine results in higher concentrations23 KB (3,267 words) - 23:45, 21 April 2024
- produces its effects by promoting the release of serotonin, dopamine, and norepinephrine in the brain, particularly serotonin. MDMA was first developed in 191285 KB (10,499 words) - 14:24, 16 April 2024
- 6-APB is a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) with Ki values of 117, 150, and 2698 nM for the norepinephrine transporter (NET),33 KB (4,870 words) - 14:34, 16 April 2024
- are increasing concentrations of the neurotransmitters dopamine and norepinephrine by either promoting release (e.g. amphetamine, methamphetamine) or by11 KB (1,055 words) - 23:00, 21 April 2024
- inhibitors (MAOIs) Norepinephrine and dopamine reuptake inhibitors (NDRIs) Selective serotonin reuptake inhibitors (SSRIs) Serotonin and norepinephrine reuptake10 KB (1,016 words) - 18:49, 17 November 2023
- acts as a weak μ-opioid receptor agonist and a reuptake inhibitor of norepinephrine and serotonin. Tramadol was developed in 1962 and launched under the22 KB (3,211 words) - 19:11, 7 April 2024
- as a norepinephrine-dopamine reuptake inhibitor (NDRI). It is most active at modulating levels of dopamine and, to a lesser extent, norepinephrine. Methylphenidate31 KB (4,250 words) - 20:18, 27 April 2024
- through the interaction of the mu receptors with serotonin, dopamine, and norepinephrine. Activation of mu receptors allows for the disinhibition of serotonin19 KB (2,797 words) - 23:08, 21 April 2024
- mechanism of action is not fully studied, but dopamine and serotonin and norepinephrine releasing activity is known to be involved. 3-MMC first appeared on18 KB (2,590 words) - 21:20, 30 April 2024
- acts as both a dopamine and norepinephrine releasing agent. This means it effectively increases the levels of the norepinephrine and dopamine in the brain17 KB (2,934 words) - 17:24, 18 January 2024
- reuptake inhibitor and a norepinephrine reuptake inhibitor, meaning that it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters19 KB (2,684 words) - 18:04, 30 July 2022
- primarily as both a dopamine and norepinephrine releasing agent. This means it effectively increases the levels of the norepinephrine and dopamine neurotransmitters17 KB (3,024 words) - 17:25, 18 January 2024
- produces its activity by increasing the levels of serotonin, dopamine, and norepinephrine in the brain. The synthesis and pharmacology of 3-FPM was first reported15 KB (2,265 words) - 06:42, 8 September 2023
- mechanism of action involves increasing levels of serotonin, dopamine, and norepinephrine in the brain.[citation needed] Cocaine is one of the most widespread47 KB (6,288 words) - 08:08, 3 May 2024